Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 20 | 2020 | 2207 | 1.770 |
Why?
|
| Monocytes | 8 | 2020 | 258 | 1.730 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2021 | 251 | 1.080 |
Why?
|
| Anti-HIV Agents | 7 | 2021 | 394 | 0.960 |
Why?
|
| Insulin Resistance | 3 | 2020 | 177 | 0.950 |
Why?
|
| HIV-1 | 6 | 2020 | 678 | 0.880 |
Why?
|
| Lipoproteins, LDL | 1 | 2020 | 61 | 0.750 |
Why?
|
| Anti-Retroviral Agents | 3 | 2019 | 139 | 0.720 |
Why?
|
| Myeloid Cells | 1 | 2019 | 28 | 0.690 |
Why?
|
| Albuminuria | 2 | 2016 | 76 | 0.670 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2016 | 91 | 0.530 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2020 | 224 | 0.500 |
Why?
|
| Middle Aged | 16 | 2021 | 9642 | 0.340 |
Why?
|
| Carotid Artery Diseases | 2 | 2020 | 22 | 0.330 |
Why?
|
| Receptors, Immunologic | 2 | 2019 | 59 | 0.310 |
Why?
|
| Coronary Vessels | 2 | 2019 | 93 | 0.300 |
Why?
|
| Inflammation | 4 | 2018 | 577 | 0.260 |
Why?
|
| Male | 16 | 2021 | 18870 | 0.240 |
Why?
|
| Humans | 21 | 2021 | 34853 | 0.240 |
Why?
|
| Female | 16 | 2021 | 19873 | 0.240 |
Why?
|
| Cross-Sectional Studies | 7 | 2020 | 2561 | 0.220 |
Why?
|
| Virus Latency | 2 | 2019 | 42 | 0.220 |
Why?
|
| Receptors, CCR2 | 2 | 2018 | 26 | 0.210 |
Why?
|
| Receptors, CCR5 | 2 | 2018 | 59 | 0.210 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2020 | 325 | 0.200 |
Why?
|
| Carotid Stenosis | 1 | 2020 | 13 | 0.190 |
Why?
|
| Fasting | 1 | 2020 | 50 | 0.190 |
Why?
|
| Antirheumatic Agents | 1 | 2020 | 33 | 0.190 |
Why?
|
| Interleukin-8 | 1 | 2020 | 59 | 0.190 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 66 | 0.190 |
Why?
|
| Viral Load | 2 | 2018 | 300 | 0.190 |
Why?
|
| Blood Platelets | 1 | 2020 | 74 | 0.190 |
Why?
|
| Oxidative Phosphorylation | 1 | 2020 | 49 | 0.190 |
Why?
|
| Autoantibodies | 1 | 2021 | 103 | 0.180 |
Why?
|
| AIDS Dementia Complex | 1 | 2021 | 107 | 0.180 |
Why?
|
| Interleukin-6 | 1 | 2020 | 140 | 0.180 |
Why?
|
| Cytokines | 2 | 2020 | 569 | 0.170 |
Why?
|
| Galectins | 1 | 2019 | 27 | 0.170 |
Why?
|
| Erythrocyte Indices | 1 | 2018 | 13 | 0.170 |
Why?
|
| Genetic Markers | 1 | 2019 | 118 | 0.170 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2019 | 57 | 0.170 |
Why?
|
| E-Selectin | 1 | 2018 | 19 | 0.170 |
Why?
|
| Blood Glucose | 1 | 2020 | 333 | 0.170 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2016 | 150 | 0.160 |
Why?
|
| Erythrocytes | 1 | 2018 | 107 | 0.160 |
Why?
|
| Imidazoles | 1 | 2018 | 124 | 0.160 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 195 | 0.160 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 162 | 0.150 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2017 | 22 | 0.150 |
Why?
|
| Lymphocyte Activation | 4 | 2020 | 222 | 0.150 |
Why?
|
| Mitochondria | 1 | 2020 | 454 | 0.140 |
Why?
|
| Receptors, IgG | 1 | 2016 | 48 | 0.140 |
Why?
|
| DNA Methylation | 1 | 2019 | 301 | 0.140 |
Why?
|
| Atrophy | 1 | 2016 | 40 | 0.140 |
Why?
|
| Deoxyguanosine | 1 | 2016 | 34 | 0.140 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 341 | 0.140 |
Why?
|
| Serum Amyloid P-Component | 1 | 2015 | 20 | 0.140 |
Why?
|
| Chronic Disease | 2 | 2016 | 469 | 0.140 |
Why?
|
| Brachial Artery | 1 | 2015 | 31 | 0.140 |
Why?
|
| Fibrosis | 1 | 2016 | 146 | 0.130 |
Why?
|
| Vasodilation | 1 | 2015 | 65 | 0.130 |
Why?
|
| Cognition | 1 | 2018 | 373 | 0.130 |
Why?
|
| Acute-Phase Proteins | 1 | 2014 | 14 | 0.130 |
Why?
|
| Chemokine CCL2 | 1 | 2016 | 82 | 0.130 |
Why?
|
| DNA, Mitochondrial | 1 | 2016 | 165 | 0.130 |
Why?
|
| Calcium | 1 | 2016 | 445 | 0.110 |
Why?
|
| Hippocampus | 1 | 2016 | 546 | 0.110 |
Why?
|
| RNA, Viral | 3 | 2020 | 287 | 0.100 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2018 | 219 | 0.100 |
Why?
|
| Retrospective Studies | 1 | 2016 | 1961 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 628 | 0.090 |
Why?
|
| Hawaii | 3 | 2020 | 1878 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 2 | 2018 | 70 | 0.070 |
Why?
|
| Aged | 1 | 2016 | 6448 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 841 | 0.060 |
Why?
|
| Disease Progression | 2 | 2016 | 580 | 0.060 |
Why?
|
| Phenotype | 2 | 2016 | 650 | 0.060 |
Why?
|
| Autoantigens | 1 | 2021 | 82 | 0.050 |
Why?
|
| CD4-CD8 Ratio | 1 | 2020 | 28 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 232 | 0.050 |
Why?
|
| Risk Factors | 2 | 2020 | 3414 | 0.050 |
Why?
|
| Uganda | 1 | 2019 | 22 | 0.040 |
Why?
|
| CpG Islands | 1 | 2019 | 91 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2019 | 72 | 0.040 |
Why?
|
| Virus Activation | 1 | 2019 | 35 | 0.040 |
Why?
|
| Sulfoxides | 1 | 2018 | 16 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2018 | 74 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 115 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 179 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2018 | 52 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2019 | 108 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 109 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 608 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2019 | 147 | 0.040 |
Why?
|
| Aorta | 1 | 2018 | 161 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 255 | 0.040 |
Why?
|
| Adult | 3 | 2018 | 11034 | 0.040 |
Why?
|
| Virus Replication | 1 | 2019 | 261 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2018 | 131 | 0.040 |
Why?
|
| Logistic Models | 1 | 2019 | 894 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2016 | 53 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1056 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 550 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 628 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2016 | 185 | 0.030 |
Why?
|
| Cell Separation | 1 | 2016 | 91 | 0.030 |
Why?
|
| Calcinosis | 1 | 2016 | 56 | 0.030 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2016 | 55 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2016 | 122 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 638 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2018 | 296 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 1289 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 1353 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 206 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2016 | 392 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 1442 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2016 | 295 | 0.030 |
Why?
|
| Prognosis | 1 | 2016 | 707 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 416 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 606 | 0.030 |
Why?
|
| DNA Damage | 1 | 2016 | 341 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 468 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 2128 | 0.030 |
Why?
|
| Aging | 1 | 2016 | 639 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 1802 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2016 | 874 | 0.020 |
Why?
|
| Animals | 1 | 2016 | 14307 | 0.010 |
Why?
|